1. NEJM -- Measurement of Residual Leukemia during Remission in Childhood Acute Lymphoblastic Leukem...
Measurement of Residual Leukemia during Remission in Childhood Acute Lymphoblastic Leukemia. The European Organization for Research and Treatme, (1998) Clin...
http://content.nejm.org/cgi/content/short/336/5/317?query=prevarrow

2. Farnesyl Transferase Inhibitor R115777 in Acute Myeloid Leukemia (AML) Patients in Second or Subs...
Men or women 18 years of age and older with Acute Myeloid Leukemia (AML) in second or subsequent remission or in remission after primary induction failure; ...
http://clinicaltrials.mayo.edu/clinicaltrialdetails.cfm?trial_id=100347

3. Phase I Study of Annamycin, a Novel Liposomal Anthracycline, in Patients with Relapsed/Refractory...
671-8 Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemias. Annamycin is ...
http://www.asco.org/portal/site/ASCO/menuitem.34d60f5624ba07fd506fe310ee37a01d/...